These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

850 related items for PubMed ID: 27167529

  • 21. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
    Jadach B, Feliczak-Guzik A, Nowak I, Milanowski B, Piotrowska-Kempisty H, Murias M, Lulek J.
    J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
    [Abstract] [Full Text] [Related]

  • 22. In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation.
    Chen B, Wang Z, Quan G, Peng X, Pan X, Wang R, Xu Y, Li G, Wu C.
    Int J Nanomedicine; 2012 Apr; 7():199-209. PubMed ID: 22275835
    [Abstract] [Full Text] [Related]

  • 23. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
    Geng H, Zhao Y, Liu J, Cui Y, Wang Y, Zhao Q, Wang S.
    Int J Pharm; 2016 Aug 20; 510(1):184-94. PubMed ID: 27262268
    [Abstract] [Full Text] [Related]

  • 24. [Structure and adsorption characterization of SBA-16 and functionalized materials].
    Zheng Z, Guo G, Hu Y, Feng F, Xu G, Tan H.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Aug 20; 28(4):768-73. PubMed ID: 21936378
    [Abstract] [Full Text] [Related]

  • 25. Enhanced functional properties of biopolymer film incorporated with curcurmin-loaded mesoporous silica nanoparticles for food packaging.
    Wu C, Zhu Y, Wu T, Wang L, Yuan Y, Chen J, Hu Y, Pang J.
    Food Chem; 2019 Aug 01; 288():139-145. PubMed ID: 30902273
    [Abstract] [Full Text] [Related]

  • 26. Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect.
    Guo Y, Gou K, Yang B, Wang Y, Pu X, Li S, Li H.
    Molecules; 2019 Sep 30; 24(19):. PubMed ID: 31575047
    [Abstract] [Full Text] [Related]

  • 27. Candesartan Cilexetil Formulations in Mesoporous Silica: Preparation, Enhanced Dissolution In Vitro, and Oral Bioavailability In Vivo.
    Guan H, Wang M, Yu S, Wang C, Chen Q, Chen Y, Zhang W, Fan J.
    J Pharm Sci; 2024 Oct 30; 113(10):3045-3053. PubMed ID: 39094942
    [Abstract] [Full Text] [Related]

  • 28. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan.
    Zhang Y, Zhi Z, Jiang T, Zhang J, Wang Z, Wang S.
    J Control Release; 2010 Aug 03; 145(3):257-63. PubMed ID: 20450945
    [Abstract] [Full Text] [Related]

  • 29. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
    Yang P, Huang S, Kong D, Lin J, Fu H.
    Inorg Chem; 2007 Apr 16; 46(8):3203-11. PubMed ID: 17371013
    [Abstract] [Full Text] [Related]

  • 30. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
    Zhang Y, Zhi Z, Li X, Gao J, Song Y.
    Int J Pharm; 2013 Sep 15; 454(1):403-11. PubMed ID: 23850816
    [Abstract] [Full Text] [Related]

  • 31. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
    Simovic S, Heard P, Hui H, Song Y, Peddie F, Davey AK, Lewis A, Rades T, Prestidge CA.
    Mol Pharm; 2009 Sep 15; 6(3):861-72. PubMed ID: 19358600
    [Abstract] [Full Text] [Related]

  • 32. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
    Thiyagarajan V, Lin SX, Lee CH, Weng CF.
    Colloids Surf B Biointerfaces; 2016 May 01; 141():120-131. PubMed ID: 26851441
    [Abstract] [Full Text] [Related]

  • 33. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen.
    Mellaerts R, Jammaer JA, Van Speybroeck M, Chen H, Van Humbeeck J, Augustijns P, Van den Mooter G, Martens JA.
    Langmuir; 2008 Aug 19; 24(16):8651-9. PubMed ID: 18630936
    [Abstract] [Full Text] [Related]

  • 34. Inclusion of fenofibrate in a series of mesoporous silicas using microwave irradiation.
    Waters LJ, Hussain T, Parkes G, Hanrahan JP, Tobin JM.
    Eur J Pharm Biopharm; 2013 Nov 19; 85(3 Pt B):936-41. PubMed ID: 23954510
    [Abstract] [Full Text] [Related]

  • 35. Optimization of tetracycline hydrochloride adsorption on amino modified SBA-15 using response surface methodology.
    Hashemikia S, Hemmatinejad N, Ahmadi E, Montazer M.
    J Colloid Interface Sci; 2015 Apr 01; 443():105-14. PubMed ID: 25540827
    [Abstract] [Full Text] [Related]

  • 36. [Improving the dissolution rate of poorly water-soluble resveratrol by the ordered mesoporous silica].
    Quan GL, Chen B, Wang ZH, Wu H, Huang XT, Wu LN, Wu CB.
    Yao Xue Xue Bao; 2012 Feb 01; 47(2):239-43. PubMed ID: 22512038
    [Abstract] [Full Text] [Related]

  • 37. Dodecylamine Template-Based Hexagonal Mesoporous Silica (HMS) as a Carrier for Improved Oral Delivery of Fenofibrate.
    Jadhav NV, Vavia PR.
    AAPS PharmSciTech; 2017 Oct 01; 18(7):2764-2773. PubMed ID: 28353172
    [Abstract] [Full Text] [Related]

  • 38. Tadalafil inclusion in microporous silica as effective dissolution enhancer: optimization of loading procedure and molecular state characterization.
    Mehanna MM, Motawaa AM, Samaha MW.
    J Pharm Sci; 2011 May 01; 100(5):1805-18. PubMed ID: 21374616
    [Abstract] [Full Text] [Related]

  • 39. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
    Kumar R, Singh A, Garg N, Siril PF.
    Ultrason Sonochem; 2018 Jan 01; 40(Pt A):686-696. PubMed ID: 28946474
    [Abstract] [Full Text] [Related]

  • 40. Nanoconfinement of a Pharmaceutical Cocrystal with Praziquantel in Mesoporous Silica: The Influence of the Solid Form on Dissolution Enhancement.
    Salas-Zúñiga R, Mondragón-Vásquez K, Alcalá-Alcalá S, Lima E, Höpfl H, Herrera-Ruiz D, Morales-Rojas H.
    Mol Pharm; 2022 Feb 07; 19(2):414-431. PubMed ID: 34967632
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.